Anti-VEGF Injections and Glaucoma Surgery.
Sign Up to like & getrecommendations! Published in 2017 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2017.0148
Abstract: Intravitreous injections of anti–vascular endothelial growth factor (VEGF) drugs are used commonly to treat retinal diseases, including age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. Injections of any agent into the vitreous increase… read more here.
Keywords: glaucoma surgery; number; surgery; anti vegf ... See more keywords
Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2018.3578
Abstract: Importance Loss to follow-up (LTFU) after anti–vascular endothelial growth factor (anti-VEGF) injections increases the risk of vision loss among patients with neovascular age-related macular degeneration (nAMD). Objective To report rates of LTFU among patients with… read more here.
Keywords: anti vegf; among patients; age; loss follow ... See more keywords
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti–Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2018.6786
Abstract: Importance Identifying the factors that are associated with the magnitude of treatment benefits from anti–vascular endothelial growth factor (anti-VEGF) therapy for diabetic macular edema (DME) may help refine treatment expectations. Objective To identify the baseline… read more here.
Keywords: anti vegf; improvement; subfield thickness; factors associated ... See more keywords
Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.3788
Abstract: Importance Anti-vascular endothelial growth factor (VEGF) therapy for retinopathy of prematurity (ROP) has potential ocular and systemic advantages compared with laser, but we believe the systemic risks of anti-VEGF therapy in preterm infants are poorly… read more here.
Keywords: vegf therapy; anti vegf; therapy; preterm infants ... See more keywords
Anti-Angiogenic Nanomicelles For the Topical Delivery of Aflibercept to Treat Retinal Neovascular Disease.
Sign Up to like & getrecommendations! Published in 2021 at "Advanced materials"
DOI: 10.1002/adma.202108360
Abstract: The traditional intravitreal injection delivery of anti-vascular endothelial growth factor (anti-VEGF) to the posterior segment of the eye for treatment of retinal diseases is invasive and associated with sight-threatening complications. To avoid such complications, there… read more here.
Keywords: anti vegf; nanomicelles topical; delivery; anti angiogenic ... See more keywords
Injectable Anti‐Inflammatory Supramolecular Nanofiber Hydrogel to Promote Anti‐VEGF Therapy in Age‐Related Macular Degeneration Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202204994
Abstract: Age‐related macular degeneration (AMD) is a major cause of visual impairment and severe vision loss worldwide, while the currently available treatments are often unsatisfactory. Previous studies have demonstrated both inflammation and oxidative‐stress‐induced damage to the… read more here.
Keywords: age related; hydrogel; anti vegf; vegf therapy ... See more keywords
The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
Sign Up to like & getrecommendations! Published in 2018 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-018-3907-y
Abstract: PurposeReal-life studies on long-term functional outcome of anti-VEGF treatment for wet age-related macular degeneration (wAMD) are limited. We therefore assessed the 10-year outcomes in our patients.MethodsIn this retrospective study, all patients with newly diagnosed wAMD… read more here.
Keywords: anti vegf; amd beyond; eyes wet; treatment ... See more keywords
The fate of eyes with wet AMD beyond 4 years of anti-VEGF therapy
Sign Up to like & getrecommendations! Published in 2018 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-018-4004-y
Abstract: Dear Editor: We would like to address several challenges that have arisen from the study by Garweg et al. [1] which can be specifically summarized below. The first inclusion criterion for the patients in this… read more here.
Keywords: anti vegf; bcva; treatment; therapy ... See more keywords
Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience
Sign Up to like & getrecommendations! Published in 2018 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-018-4095-5
Abstract: Dear Editor, We thank our colleagues Dan Călugăru and Mihai Călugăru for their interest in our paper recently published in this Journal [1]. We thank them for highlighting their contribution to retinal vein occlusion (RVO)… read more here.
Keywords: anti vegf; vegf agents; vein occlusion; treatment ... See more keywords
Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-020-04924-0
Abstract: To define a “super stable” subset of polypoidal choroidal vasculopathy (PCV) patients that have a long period of remission following anti-vascular endothelial growth factor (VEGF) therapy. Twenty-one eyes that showed no recurrence for over 18… read more here.
Keywords: anti vegf; choroidal; remission; group ... See more keywords
The polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-020-04977-1
Abstract: To estimate the polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy (PCV) and clarify its baseline characteristics. The PubMed, EMBASE, and Ovid were searched up to January 2020 to identify… read more here.
Keywords: anti vegf; regression; polyp regression; treatment ... See more keywords